Kohei Takei
Papers
1
Total Citations
12
H-Index
1
About
Dr. Kohei Takei is a urologic oncologist whose research focuses on improving surgical outcomes and risk stratification for patients with prostate cancer, particularly those undergoing robot-assisted radical prostatectomy. His key contributions center on refining predictive models to guide surgical decision-making in intermediate to high-risk disease. In his most cited work, Dr. Takei investigated the utility of prostate-specific antigen (PSA) density combined with detailed biopsy core characteristics to forecast oncological outcomes. This study, published in 2017 with 12 citations, provides critical insights for surgeons determining the necessity of extended resection or lymph node dissection. By demonstrating that biopsy core details significantly enhance the predictive value of traditional metrics, Dr. Takei has helped advance personalized surgical planning, potentially reducing overtreatment while ensuring oncologic control. His work bridges the gap between pathological findings and clinical decision-making, offering a practical framework for urologists navigating complex cases. Dr. Takei’s research underscores a commitment to evidence-based, patient-tailored approaches in the surgical management of prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1